Swiss - Delayed Quote CHF
Evolva Holding SA (EVE.SW)
1.1000
-0.0450
(-3.93%)
At close: May 9 at 4:59:05 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Gerhard Lobmaier | Chief Operations Officer | -- | -- | 1969 |
| Thomas Schneckenburger C.F.A., Ph.D. | Head of Investor & Corporate Relations | -- | -- | -- |
| Ms. Anne De Vos | Head of Sales | -- | -- | 1964 |
| Ms. Astrid Schafer | Head of Innovation | -- | -- | 1973 |
| Dr. Luc Gruner | Executive Officer | -- | -- | 1952 |
Evolva Holding SA
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Evolva Holding SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was incorporated in 2001 and is headquartered in Reinach, Switzerland.
Corporate Governance
Evolva Holding SA’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
February 21, 2025 at 10:59 AM UTC
Evolva Holding SA Earnings Date
Recent Events
October 31, 2017 at 12:00 AM UTC
Dividend Date
Related Tickers
ADXN.SW Addex Therapeutics Ltd
0.0580
+3.57%
SANN.SW Santhera Pharmaceuticals Holding AG
13.18
-0.15%
IDIA.SW Idorsia Ltd
1.2820
-2.88%
SLRN Acelyrin, Inc.
2.3600
-4.07%
DTIL Precision BioSciences, Inc.
5.13
-0.39%
CRIS Curis, Inc.
1.8900
-10.00%
JAGX Jaguar Health, Inc.
8.51
-2.13%
LXRX Lexicon Pharmaceuticals, Inc.
0.7010
+1.73%
ALT Altimmune, Inc.
5.59
-3.62%